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Summary: 
Familial amyotrophic lateral sclerosis (FALS) cases linked to SOD1 mutations may 
sometimes present with unusual clinical features such as pure lower motor neuron 
involvement or sensory signs. 
We describe a FALS pedigree with the L144F SOD1 mutation in which all cases had 
respiratory involvement as a first symptom. 
Although atypical clinical features are not rare in ALS families, this is the first pedigree with 
respiratory-onset in three affected members. This unusual presentation led to delayed 
diagnosis in the proband and highlights the fact that respiratory-onset can occur in familial 
ALS cases carrying SOD1 mutation. 
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Introduction: 
Amyotrophic lateral sclerosis (ALS) is a devastating disorder of unknown origin. In 
approximately 20% of cases, familial aggregation occurs.(1) 12 to 23.5 % of patients with a 
diagnosis of familial ALS (FALS) and 0 to 7.3% of patients with a diagnosis of sporadic ALS 
have in different populations been associated with a SOD1 gene mutation.(2) More recently, 
other genes have been implicated but account for less than 10% of FALS.(3) To date, more 
than 130 SOD1 mutations have been identified and some atypical phenotypes have been 
described such as 1) a long duration, more than 10 or 20 years,(4) 2) pure lower motor neuron 
disease,(5) or 3) sensory or oculo-motor signs.(6-7) Phenotypic heterogeneity within families 
has also been shown. Respiratory-onset is usually rare in ALS, accounting for less than 5% of 
cases.(8)  
Here we present, to our knowledge, the first ALS family with respiratory-onset and 
SOD1 mutation. All affected family members had respiratory muscle weakness as the first 
symptom.   
 
Case reports: 
A 54 year-old man was referred to our center in August 2007, because of an eight 
month-history of intense fatigue, dyspnea and orthopnea. At the first visit in January 2007, the 
neurological examination was normal in the bulbar region and the four limbs without clinical 
signs for upper motor neuron and lower motor neuron involvement conversely to pulmonary 
investigation that indicated the need for nocturnal non-invasive ventilation (NIV). At that 
time, slow vital capacity was 44% and forced vital capacity was 47 % of normal values. The 
patient did not complain of morning headhache, lack of concentration or sleep disturbance. In 
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March 2007, his neurologist only noted intense fatigue. In June, the patient complained of 
dyspnea and electromyography showed normal conduction velocities with low CMAP 
amplitudes in the legs together with denervation at needle examination. Respiratory 
involvement progressed and non invasive ventilation was required in July 2007. When he was 
first seen for in our department, the ALSFRS-R scale was scored 32/48. On physical 
examination, there were both upper and lower motor neuron signs in the right upper and lower 
limbs with brisk tendon reflexes, fasciculations and moderate amyotrophy. The plantar 
response was flexor on both sides. Nerve conduction studies were normal, but needle EMG 
showed severe denervation and fibrillations in all four limbs. Disability progressed rapidly, 
and the ALSFRS-R scale was rated 22/48 in January 2008. In September, the patient had 
severe tetraparesis as well as bulbar palsy with dysphonia, dysphagia, paresis of the tongue, 
vocal cords and pharyngeal muscles. NIV was used both during night and day.  
This patient indicated that his mother died at 83 years of age in 2004 after several 
years of progressive motor impairment. Her medical history was obtained from her file. Her 
ALS began with dyspnea in 1990 and NIV was started in 1994. By 2000 she had moderate 
weakness in the four limbs together with axial involvement. At that time neurological 
examination showed for the first time both upper and lower motor neuron signs both in bulbar 
and limb muscles. Nerve conduction studies were normal and needle EMG showed diffuse 
denervation. She used a walker because of lumbar paraspinalis muscles weakness. In 2002, 
hypercapnia was noted (pCO2 50mmHg) despite ventilation. She died in 2004 after 14 years 
of ALS. The formal diagnosis of ALS was suspected but could not be ascertained by her 
neurologists because of the atypical respiratory onset and the slow evolution. 
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The maternal uncle of the proband, A Serbian man who lived in Belgrade, developed 
dyspnea followed by diffuse amyotrophy at age of 65. His clinical state progressively 
worsened and he died after 5 years of symptoms (figure 1).  
Two living siblings of our proband were examined both clinically and 
neurophysiologically without findings suggestive of ALS. A third sibling died of heart 
ischemia. 
 
SOD1 gene analysis: 
After written informed consent, blood was collected and DNA extracted from our 
proband. Five exon portions and flanking splice junctions of the SOD1 gene were amplified 
by PCR as previously described.(9) PCR products were sequenced in both strands and 
analyses were done with sequence analysis software against sequences of reference 
GeneBank: L44135 to L44139. Mutational analysis revealed a missense mutation in exon 5 
Leu144Phe (L144F) (Figure 2). 
 
Discussion: 
The L144F mutation was one of the first SOD1 mutations found in ALS.(10) Since 
that time three L144F FALS pedigrees have been described which shared several 
characteristics, including origin from western Mediterranean countries (Italy and Istro-
Rumania), slow evolution and a predominantly lower limb onset (Table 1). Cognitive 
involvement has also been described in these families and, although rare, this was the first 
SOD1 mutation in which dementia was shown [case V-4 (11); case IV-6(12)]. 
 6 
 
In our family, the disease was characterized by respiratory-onset, contrasting with 
other SOD1-linked FALS pedigrees, with or without the L144F mutation. The frequency of 
respiratory-onset in ALS is estimated between 2.7 and 5 %.(8,13) This unusual presentation 
may explain the delayed diagnosis in the mother. In her case, ALS was initially excluded 
because of the predominant respiratory impairment and the slow evolution, but the medical 
file was clear enough to indicate the respiratory onset and clinical signs of upper and lower 
motor neurons with abnormalities at EMG typical of ALS. Descriptions of the third patient, 
the proband’s uncle were considered convincing but despite our inquiries and study of data 
bases in Serbia, his clinical file could not be obtained. 
Our family originated from Serbia, a country near Italy and Rumania. Other SOD1 
mutations also originate from specific countries: the A4V mutation is frequent in the United 
States but associated with an Italian origin,(14) the D90A mutation originates from 
Sweden,(6) and the R115G mutation is found exclusively in the German population.(15) 
Although not genetically ascertained, L144F may originate from Serbia as 17 families 
carrying the mutation have been identified there (unpublished data), while single pedigrees or 
cases have been found in surrounding countries. 
Although a significant number of patients with SOD1 mutations have limb and 
particularly lower limb onset, the presented family highlights the fact that respiratory onset 
can occur in familial ALS linked to SOD1 mutation. Physicians should be aware of that 
possible feature as, in at least two of our three cases, the diagnosis was delayed or not 
confirmed until late in the course of the disease. 
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Table 1: Clinical features of L144F (according to the new classification) SOD1 ALS patients  
Origin Gender Age of onset (SD) Site of onset ALS duration (SD) References 
Italy M 53 yrs LL  Alsod.org 
Italy M 51yrs  LL   
Italy M 50 yrs UL   
Italy F 55 yrs UL   
Italy M 64 yrs LL   
Italy M 24 yrs LL   
Istro-Rumania M 49 yrs UL 1.5 yrs Masè 
Istro-Rumania M 51 yrs LL 6 yrs  
Istro-Rumania M 58 yrs LL 7 yrs  
Istro-Rumania F 72 yrs LL 5 yrs  
Istro-Rumania F 66 yrs LL 6 yrs  
Istro-Rumania F 67 yrs UL 13 yrs  
Istro-Rumania F 47 yrs LL 4 yrs  
Istro-Rumania M 54 yrs LL 4 yrs  
Istro-Rumania F 54 yrs LL 1 yrs  
Italy F 18 yrs LL 4 yrs Ferrerra 
Italy F 63 yrs LL 10 yrs  
Italy F 38 yrs LL 8 yrs  
Italy F 33 yrs LL 34 yrs  
Italy M 67 yrs LL 2 yrs  
Italy F 64 yrs LL 8 yrs  
Italy F 72 yrs LL 2 yrs  
Serbia M 54 yrs Respiratory Still Alive Corcia 
Serbia F  Respiratory 14 yrs  
Serbia M  Respiratory 5 yrs  
Mean (±SD)  53 yrs (14) UL 72%; LL 16%; Resp 12% 7.5 yrs (7.6)  
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M: Male; F: Female, UL: Upper Limb; LL: Lower Limb; U: Unknown 


